Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, et al: 50 Year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham heart study: A cohort study. Lancet. 386:154–162. 2015.PubMed/NCBI View Article : Google Scholar

Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, et al: Heart disease and stroke statistics-2019 update: A report from the american heart association. Circulation. 139:e56–e528. 2019.PubMed/NCBI View Article : Google Scholar

Kornej J, Börschel CS, Benjamin EJ and Schnabel RB: Epidemiology of atrial fibrillation in the 21st century: Novel methods and new insights. Circ Res. 127:4–20. 2020.PubMed/NCBI View Article : Google Scholar

Staerk L, Sherer JA, Ko D, Benjamin EJ and Helm RH: Atrial fibrillation: Epidemiology, pathophysiology, and clinical outcomes. Circ Res. 120:1501–1517. 2017.PubMed/NCBI View Article : Google Scholar

Mark DB, Anstrom KJ, Sheng S, Piccini JP, Baloch KN, Monahan KH, Daniels MR, Bahnson TD, Poole JE, Rosenberg Y, et al: Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 321:1275–1285. 2019.PubMed/NCBI View Article : Google Scholar

Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, et al: Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: The CABANA randomized clinical trial. JAMA. 321:1261–1274. 2019.PubMed/NCBI View Article : Google Scholar

Prabhu S, Taylor AJ, Costello BT, Kaye DM, McLellan AJA, Voskoboinik A, Sugumar H, Lockwood SM, Stokes MB, Pathik B, et al: Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: The CAMERA-MRI study. J Am Coll Cardiol. 70:1949–1961. 2017.PubMed/NCBI View Article : Google Scholar

Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, et al: Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 378:417–427. 2018.PubMed/NCBI View Article : Google Scholar

Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, et al: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 20:e1–e160. 2018.PubMed/NCBI View Article : Google Scholar

January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, et al: 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American college of cardiology/American heart association task force on practice guidelines and the heart rhythm society. J Am Coll Cardiol. 64:e1–e76. 2014.PubMed/NCBI View Article : Google Scholar

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, et al: 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg. 50:e1–e88. 2016.PubMed/NCBI View Article : Google Scholar

Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, et al: Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the European society of cardiology (ESC). Europace. 12:1360–1420. 2010.PubMed/NCBI View Article : Google Scholar

Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G and Kirchhof P: ESC Committee for Practice Guidelines (CPG). 2012 Focused update of the ESC guidelines for the management of atrial fibrillation: An update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European heart rhythm association. Eur Heart J. 33:2719–2747. 2012.PubMed/NCBI View Article : Google Scholar

Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, et al: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 347:1825–1833. 2002.PubMed/NCBI View Article : Google Scholar

Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, et al: A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 347:1834–1840. 2002.PubMed/NCBI View Article : Google Scholar

Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, Walter S and Tebbe U: STAF Investigators. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The strategies of treatment of atrial fibrillation (STAF) study. J Am Coll Cardiol. 41:1690–1696. 2003.PubMed/NCBI View Article : Google Scholar

Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, et al: Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 383:1305–1316. 2020.PubMed/NCBI View Article : Google Scholar

January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, et al: 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of cardiology/american heart association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons. Circulation. 140:e125–e151. 2019.PubMed/NCBI View Article : Google Scholar

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, et al: 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS): The task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European heart rhythm association (EHRA) of the ESC. Eur Heart J. 42:373–498. 2021.PubMed/NCBI View Article : Google Scholar

Doyle JF and Ho KM: Benefits and risks of long-term amiodarone therapy for persistent atrial fibrillation: A meta-analysis. Mayo Clin Proc. 84:234–242. 2009.PubMed/NCBI View Article : Google Scholar

Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, et al: Amiodarone to prevent recurrence of atrial fibrillation. Canadian trial of atrial fibrillation investigators. N Engl J Med. 342:913–920. 2000.PubMed/NCBI View Article : Google Scholar

Khan AR, Khan S, Sheikh MA, Khuder S, Grubb B and Moukarbel GV: Catheter ablation and antiarrhythmic drug therapy as first- or second-line therapy in the management of atrial fibrillation: Systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 7:853–860. 2014.PubMed/NCBI View Article : Google Scholar

Andrade JG: Ablation as first-line therapy for atrial fibrillation. Eur Cardiol. 18(e46)2023.PubMed/NCBI View Article : Google Scholar

Turagam MK, Musikantow D, Whang W, Koruth JS, Miller MA, Langan MN, Sofi A, Choudry S, Dukkipati SR and Reddy VY: Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation: A meta-analysis of randomized clinical trials. JAMA Cardiol. 6:697–705. 2021.PubMed/NCBI View Article : Google Scholar

Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R, et al: 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: A report of the american college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 149:e1–e156. 2024.PubMed/NCBI View Article : Google Scholar

Hocini M, Sanders P, Deisenhofer I, Jaïs P, Hsu LF, Scavée C, Weerasoriya R, Raybaud F, Macle L, Shah DC, et al: Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses. Circulation. 108:1172–1175. 2003.PubMed/NCBI View Article : Google Scholar

Chen YW, Bai R, Lin T, Salim M, Sang CH, Long DY, Yu RH, Tang RB, Guo XY, Yan XL, et al: Pacing or ablation: Which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome? Pacing Clin Electrophysiol. 37:403–411. 2014.PubMed/NCBI View Article : Google Scholar

Inada K, Yamane T, Tokutake K, Yokoyama K, Mishima T, Hioki M, Narui R, Ito K, Tanigawa S, Yamashita S, et al: The role of successful catheter ablation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses: Outcome during a 5-year follow-up. Europace. 16:208–213. 2014.PubMed/NCBI View Article : Google Scholar

Koopman P, Nuyens D, Garweg C, La Gerche A, De Buck S, Van Casteren L, Alzand B, Willems R and Heidbuchel H: Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation. Europace. 13:1386–1393. 2011.PubMed/NCBI View Article : Google Scholar

Furlanello F, Lupo P, Pittalis M, Foresti S, Vitali-Serdoz L, Francia P, De Ambroggi G, Ferrero P, Nardi S, Inama G, et al: Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition. J Cardiovasc Electrophysiol. 19:457–462. 2008.PubMed/NCBI View Article : Google Scholar

Pathak RK, Elliott A, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Hendriks JM, Twomey D, Kalman JM, Abhayaratna WP, et al: Impact of CARDIOrespiratory fitness on arrhythmia recurrence in obese individuals with atrial fibrillation: The CARDIO-FIT study. J Am Coll Cardiol. 66:985–996. 2015.PubMed/NCBI View Article : Google Scholar

Deshpande R, AlKhadra Y, Singanallur P, Botchway A and Labedi M: Outcomes of catheter ablation versus antiarrhythmic therapy in patients with atrial fibrillation: A systematic review and meta-analysis. J Interv Card Electrophysiol. 65:773–802. 2022.PubMed/NCBI View Article : Google Scholar

Deedwania PC and Lardizabal JA: Atrial fibrillation in heart failure: A comprehensive review. Am J Med. 123:198–204. 2010.PubMed/NCBI View Article : Google Scholar

Nerheim P, Birger-Botkin S, Piracha L and Olshansky B: Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation. 110:247–252. 2004.PubMed/NCBI View Article : Google Scholar

Raymond RJ, Lee AJ, Messineo FC, Manning WJ and Silverman DI: Cardiac performance early after cardioversion from atrial fibrillation. Am Heart J. 136:435–442. 1998.PubMed/NCBI View Article : Google Scholar

January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, et al: 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol. 74:104–132. 2019.PubMed/NCBI View Article : Google Scholar

Şaylık F, Çınar T, Akbulut T and Hayıroğlu Mİ: Comparison of catheter ablation and medical therapy for atrial fibrillation in heart failure patients: A meta-analysis of randomized controlled trials. Heart Lung. 57:69–74. 2023.PubMed/NCBI View Article : Google Scholar

Chang TY, Chao TF, Lin CY, Lin YJ, Chang SL, Lo LW, Hu YF, Chung FP and Chen SA: Catheter ablation of atrial fibrillation in heart failure with impaired systolic function: An updated meta-analysis of randomized controlled trials. J Chin Med Assoc. 86:11–18. 2023.PubMed/NCBI View Article : Google Scholar

Zafrir B, Lund LH, Laroche C, Ruschitzka F, Crespo-Leiro MG, Coats AJS, Anker SD, Filippatos G, Seferovic PM, Maggioni AP, et al: Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: A report from 14 964 patient in the European society of cardiology heart failure long-term registry. Eur Heart J. 39:4277–4284. 2018.PubMed/NCBI View Article : Google Scholar

Sartipy U, Dahlström U, Fu M and Lund LH: Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction. JACC Heart Fail. 5:565–574. 2017.PubMed/NCBI View Article : Google Scholar

Gu G, Wu J, Gao X, Liu M, Jin C and Xu Y: Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction: A meta-analysis. Clin Cardiol. 45:786–793. 2022.PubMed/NCBI View Article : Google Scholar

Kawamura I, Aikawa T, Yokoyama Y, Takagi H and Kuno T: Catheter ablation for atrial fibrillation in elderly patients: Systematic review and a meta-analysis. Pacing Clin Electrophysiol. 45:59–71. 2022.PubMed/NCBI View Article : Google Scholar

Lee WC, Wu PJ, Chen HC, Fang HY, Liu PY and Chen MC: Efficacy and safety of ablation for symptomatic atrial fibrillation in elderly patients: A meta-analysis. Front Cardiovasc Med. 8(734204)2021.PubMed/NCBI View Article : Google Scholar

Li F, Zhang L, Wu LD, Zhang ZY, Liu HH, Zhang ZY, Zhang J, Qian LL and Wang RX: Do elderly patients with atrial fibrillation have comparable ablation outcomes compared to younger ones? Evidence from pooled clinical studies. J Clin Med. 11(4468)2022.PubMed/NCBI View Article : Google Scholar

Spragg DD, Dalal D, Cheema A, Scherr D, Chilukuri K, Cheng A, Henrikson CA, Marine JE, Berger RD, Dong J and Calkins H: Complications of catheter ablation for atrial fibrillation: Incidence and predictors. J Cardiovasc Electrophysiol. 19:627–631. 2008.PubMed/NCBI View Article : Google Scholar

Leong-Sit P, Zado E, Callans DJ, Garcia F, Lin D, Dixit S, Bala R, Riley MP, Hutchinson MD, Cooper J, et al: Efficacy and risk of atrial fibrillation ablation before 45 years of age. Circ Arrhythm Electrophysiol. 3:452–457. 2010.PubMed/NCBI View Article : Google Scholar

Kalman JM, Sanders P, Rosso R and Calkins H: Should we perform catheter ablation for asymptomatic atrial fibrillation? Circulation. 136:490–499. 2017.PubMed/NCBI View Article : Google Scholar

Rienstra M, Vermond RA, Crijns HJ, Tijssen JG and Van Gelder IC: RACE Investigators. Asymptomatic persistent atrial fibrillation and outcome: Results of the RACE study. Heart Rhythm. 11:939–945. 2014.PubMed/NCBI View Article : Google Scholar

Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu MI, Rasmussen LH, Sinagra G, Petrescu L, Tavazzi L, Maggioni AP and Lip GYH: Asymptomatic atrial fibrillation: Clinical correlates, management, and outcomes in the EORP-AF pilot general registry. Am J Med. 128:509–518.e2. 2015.PubMed/NCBI View Article : Google Scholar

Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, Ellinor PT, Cheng S, Vasan RS, Lee DS, et al: Atrial fibrillation begets heart failure and vice versa: Temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 133:484–492. 2016.PubMed/NCBI View Article : Google Scholar

Mohanty S, Santangeli P, Mohanty P, Di Biase L, Holcomb S, Trivedi C, Bai R, Burkhardt D, Hongo R, Hao S, et al: Catheter ablation of asymptomatic longstanding persistent atrial fibrillation: impact on quality of life, exercise performance, arrhythmia perception, and arrhythmia-free survival. J Cardiovasc Electrophysiol. 25:1057–1064. 2014.PubMed/NCBI View Article : Google Scholar

Wu L, Lu Y, Zheng L, Qiao YU, Chen G, Ding L, Hou B, Sun W, Liew R, Zhang S and Yao Y: Comparison of radiofrequency catheter ablation between asymptomatic and symptomatic persistent atrial fibrillation: A propensity score matched analysis. J Cardiovasc Electrophysiol. 27:531–535. 2016.PubMed/NCBI View Article : Google Scholar

Pak M, Kobori A, Shizuta S, Sasaki Y, Toyota T, Yoshizawa T, Inoue K, Kaitani K, Kurotobi T, Morishima I, et al: The impact of catheter ablation for patients with asymptomatic atrial fibrillation: Subanalysis of kansai plus atrial fibrillation (kpaf) registry. Eur Heart J. 41 (Suppl 2)(ehaa946.0442)2020.

Kawaji T, Shizuta S, Tanaka M, Nishiwaki S, Aizawa T, Yamagami S, Komasa A, Yoshizawa T, Kato M, Yokomatsu T, et al: Prognostic impact of catheter ablation in patients with asymptomatic atrial fibrillation. PLoS One. 17(e0279178)2022.PubMed/NCBI View Article : Google Scholar

Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, Josephson RA, Kellen JC, Klein RC, Krahn AD, et al: Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation follow-up investigation of rhythm management (AFFIRM) study. Circulation. 109:1509–1513. 2004.PubMed/NCBI View Article : Google Scholar

Barra S, Baran J, Narayanan K, Boveda S, Fynn S, Heck P, Grace A, Agarwal S, Primo J, Marijon E and Providência R: Association of catheter ablation for atrial fibrillation with mortality and stroke: A systematic review and meta-analysis. Int J Cardiol. 266:136–142. 2018.PubMed/NCBI View Article : Google Scholar

Barra S, Narayanan K, Boveda S, Primo J, Gonçalves H, Baran J, Agarwal S, Marijon E and Providência R: Atrial Fibrillation ablation and reduction of stroke events: Understanding the paradoxical lack of evidence. Stroke. 50:2970–2976. 2019.PubMed/NCBI View Article : Google Scholar

Mao YJ, Wang H, Chen JX and Huang PF: Meta-analysis of medical management versus catheter ablation for atrial fibrillation. Rev Cardiovasc Med. 21:419–432. 2020.PubMed/NCBI View Article : Google Scholar

Shi LZ, Heng R, Liu SM and Leng FY: Effect of catheter ablation versus antiarrhythmic drugs on atrial fibrillation: A meta-analysis of randomized controlled trials. Exp Ther Med. 10:816–822. 2015.PubMed/NCBI View Article : Google Scholar

Freedman B, Martinez C, Katholing A and Rietbrock S: Residual risk of stroke and death in anticoagulant-treated patients with atrial fibrillation. JAMA Cardiol. 1:366–368. 2016.PubMed/NCBI View Article : Google Scholar

Balsam P, Tymińska A, Ozierański K, Zaleska M, Żukowska K, Szepietowska K, Maciejewski K, Peller M, Grabowski M, Lodziński P, et al: Randomized controlled clinical trials versus real-life atrial fibrillation patients treated with oral anticoagulants. Do we treat the same patients? Cardiol J. 27:590–599. 2020.PubMed/NCBI View Article : Google Scholar

Camm AJ, Amarenco P, Haas S, Hess S, Kirchhof P, Lambelet M, Bach M and Turpie AGG: Real-world vs randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUS. Europace. 21:421–427. 2019.PubMed/NCBI View Article : Google Scholar

Ganesan AN, Shipp NJ, Brooks AG, Kuklik P, Lau DH, Lim HS, Sullivan T, Roberts-Thomson KC and Sanders P: Long-term outcomes of catheter ablation of atrial fibrillation: A systematic review and meta-analysis. J Am Heart Assoc. 2(e004549)2013.PubMed/NCBI View Article : Google Scholar

Gaita F, Caponi D, Scaglione M, Montefusco A, Corleto A, Di Monte F, Coin D, Di Donna P and Giustetto C: Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation. Circ Arrhythm Electrophysiol. 1:269–275. 2008.PubMed/NCBI View Article : Google Scholar

Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T, Neven K, Köktürk B, Konstantinidou M, Metzner A, et al: Long-term results of catheter ablation in paroxysmal atrial fibrillation: Lessons from a 5-year follow-up. Circulation. 122:2368–2377. 2010.PubMed/NCBI View Article : Google Scholar

Wijffels MC, Kirchhof CJ, Dorland R and Allessie MA: Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 92:1954–1968. 1995.PubMed/NCBI View Article : Google Scholar

Wokhlu A, Monahan KH, Hodge DO, Asirvatham SJ, Friedman PA, Munger TM, Bradley DJ, Bluhm CM, Haroldson JM and Packer DL: Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect. J Am Coll Cardiol. 55:2308–2316. 2010.PubMed/NCBI View Article : Google Scholar

Ware JE, Snow KK, Kosinski M and Gandek B: SF-36 Health Survey: Manual and Interpretation Guide. New England Medical Center, The Health Institute, Boston, 1993.

Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, Goette A, Hindricks G, Hohnloser S, Kappenberger L, et al: Outcome parameters for trials in atrial fibrillation: Executive summary. Eur Heart J. 28:2803–2817. 2007.PubMed/NCBI View Article : Google Scholar

Reynolds MR, Ellis E and Zimetbaum P: Quality of life in atrial fibrillation: Measurement tools and impact of interventions. J Cardiovasc Electrophysiol. 19:762–768. 2008.PubMed/NCBI View Article : Google Scholar

Jaïs P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, Hocini M, Extramiana F, Sacher F, Bordachar P, et al: Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: The A4 study. Circulation. 118:2498–2505. 2008.PubMed/NCBI View Article : Google Scholar

Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, Bash D, Schweikert R, Brachmann J, Gunther J, et al: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: A randomized trial. JAMA. 293:2634–2640. 2005.PubMed/NCBI View Article : Google Scholar

Cosedis Nielsen J, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS and Hansen PS: Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med. 367:1587–1595. 2012.PubMed/NCBI View Article : Google Scholar

Morillo CA, Verma A, Connolly SJ, Kuck KH, Nair GM, Champagne J, Sterns LD, Beresh H, Healey JS and Natale A: RAAFT-2 Investigators. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): A randomized trial. JAMA. 311:692–700. 2014.PubMed/NCBI View Article : Google Scholar

Walfridsson H, Walfridsson U, Nielsen JC, Johannessen A, Raatikainen P, Janzon M, Levin LA, Aronsson M, Hindricks G, Kongstad O, et al: Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: Results on health-related quality of life and symptom burden. The MANTRA-PAF trial. Europace. 17:215–221. 2015.PubMed/NCBI View Article : Google Scholar

Maesen B, van der Heijden CAJ, Bidar E, Vos R, Athanasiou T and Maessen JG: Patient-reported quality of life after stand-alone and concomitant arrhythmia surgery: A systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. 34:339–348. 2022.PubMed/NCBI View Article : Google Scholar

Siontis KC, Ioannidis JPA, Katritsis GD, Noseworthy PA, Packer DL, Hummel JD, Jais P, Krittayaphong R, Mont L, Morillo CA, et al: Radiofrequency ablation versus antiarrhythmic drug therapy for atrial fibrillation: Meta-analysis of quality of life, morbidity, and mortality. JACC Clin Electrophysiol. 2:170–180. 2016.PubMed/NCBI View Article : Google Scholar

Raine D, Langley P, Shepherd E, Lord S, Murray S, Murray A and Bourke JP: Effect of catheter ablation on quality of life in patients with atrial fibrillation and its correlation with arrhythmia outcome. Open Heart. 2(e000302)2015.PubMed/NCBI View Article : Google Scholar

Dagres N, Varounis C, Flevari P, Piorkowski C, Bode K, Rallidis LS, Tsougos E, Leftheriotis D, Sommer P, Hindricks G and Kremastinos DT: Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials. Am Heart J. 158:15–20. 2009.PubMed/NCBI View Article : Google Scholar

Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P, Gulletta S, Gugliotta F, Pappone A, Santinelli V, et al: Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol. 42:185–197. 2003.PubMed/NCBI View Article : Google Scholar

Nademanee K, Schwab MC, Kosar EM, Karwecki M, Moran MD, Visessook N, Michael AD and Ngarmukos T: Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. J Am Coll Cardiol. 51:843–849. 2008.PubMed/NCBI View Article : Google Scholar

Hunter RJ, McCready J, Diab I, Page SP, Finlay M, Richmond L, French A, Earley MJ, Sporton S, Jones M, et al: Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death. Heart. 98:48–53. 2012.PubMed/NCBI View Article : Google Scholar

Lin YJ, Chao TF, Tsao HM, Chang SL, Lo LW, Chiang CE, Hu YF, Hsu PF, Chuang SY, Li CH, et al: Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher. Europace. 15:676–684. 2013.PubMed/NCBI View Article : Google Scholar

Friberg L, Tabrizi F and Englund A: Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: Data from Swedish health registries. Eur Heart J. 37:2478–2487. 2016.PubMed/NCBI View Article : Google Scholar

Saliba W, Schliamser JE, Lavi I, Barnett-Griness O, Gronich N and Rennert G: Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality: A propensity score-matched analysis. Heart Rhythm. 14:635–642. 2017.PubMed/NCBI View Article : Google Scholar

Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Packer D and Skanes A: Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 111:1100–1105. 2005.PubMed/NCBI View Article : Google Scholar

Patel NJ, Deshmukh A, Pau D, Goyal V, Patel SV, Patel N, Agnihotri K, Asirvatham S, Noseworthy P, Di Biase L, Natale A and Viles-Gonzalez JF: Contemporary utilization and safety outcomes of catheter ablation of atrial flutter in the United States: Analysis of 89,638 procedures. Heart Rhythm. 13:1317–1325. 2016.PubMed/NCBI View Article : Google Scholar

Sra J: Atrial fibrillation ablation complications. J Interv Card Electrophysiol. 22:167–172. 2008.PubMed/NCBI View Article : Google Scholar

Steinbeck G, Sinner MF, Lutz M, Müller-Nurasyid M, Kääb S and Reinecke H: Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: A nationwide in-hospital analysis of administrative data for Germany in 2014. Eur Heart J. 39:4020–4029. 2018.PubMed/NCBI View Article : Google Scholar

Gupta A, Perera T, Ganesan A, Sullivan T, Lau DH, Roberts-Thomson KC, Brooks AG and Sanders P: Complications of catheter ablation of atrial fibrillation: A systematic review. Circ. Arrhythmia Electrophysiol. 6:1082–1088. 2013.PubMed/NCBI View Article : Google Scholar

Prudente LA, Moorman JR, Lake D, Xiao Y, Greebaum H, Mangrum JM, DiMarco JP and Ferguson JD: Femoral vascular complications following catheter ablation of atrial fibrillation. J Interv Card Electrophysiol. 26:59–64. 2009.PubMed/NCBI View Article : Google Scholar

Sharma PS, Padala SK, Gunda S, Koneru JN and Ellenbogen KA: Vascular complications during catheter ablation of cardiac arrhythmias: A comparison between vascular ultrasound guided access and conventional vascular access. J Cardiovasc Electrophysiol. 27:1160–1166. 2016.PubMed/NCBI View Article : Google Scholar

Edriss H, Denega T, Test V and Nugent K: Pulmonary vein stenosis complicating radiofrequency catheter ablation for atrial fibrillation: A literature review. Respir Med. 117:215–222. 2016.PubMed/NCBI View Article : Google Scholar

Fender EA, Widmer RJ, Hodge DO, Cooper GM, Monahan KH, Peterson LA, Holmes DR Jr and Packer DL: Severe pulmonary vein stenosis resulting from ablation for atrial fibrillation: Presentation, management, and clinical outcomes. Circulation. 134:1812–1821. 2016.PubMed/NCBI View Article : Google Scholar

Maclean E, Mahtani K, Roelas M, Vyas R, Butcher C, Ahluwalia N, Honarbakhsh S, Creta A, Finlay M, Chow A, et al: Transseptal puncture for left atrial ablation: Risk factors for cardiac tamponade and a proposed causative classification system. J Cardiovasc Electrophysiol. 33:1747–1755. 2022.PubMed/NCBI View Article : Google Scholar

Sorgente A, Chierchia GB, de Asmundis C, Sarkozy A, Capulzini L and Brugada P: Complications of atrial fibrillation ablation: When prevention is better than cure. Europace. 13:1526–1532. 2011.PubMed/NCBI View Article : Google Scholar

Kumar S, Ling LH, Halloran K, Morton JB, Spence SJ, Joseph S, Kistler PM, Sparks PB and Kalman JM: Esophageal hematoma after atrial fibrillation ablation: Incidence, clinical features, and sequelae of esophageal injury of a different sort. Circ Arrhythm Electrophysiol. 5:701–705. 2012.PubMed/NCBI View Article : Google Scholar

Mujović N, Marinković M, Lenarczyk R, Tilz R and Potpara TS: Catheter ablation of atrial fibrillation: An overview for clinicians. Adv Ther. 34:1897–1917. 2017.PubMed/NCBI View Article : Google Scholar

Letsas KP, Weber R, Bürkle G, Mihas CC, Minners J, Kalusche D and Arentz T: Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: The potential role of inflammation. Europace. 11:158–163. 2009.PubMed/NCBI View Article : Google Scholar

Parkash R, Wells GA, Sapp JL, Healey JS, Tardif JC, Greiss I, Rivard L, Roux JF, Gula L, Nault I, et al: Effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: A randomized, open-label clinical trial [SMAC-AF (substrate modification with aggressive blood pressure control)]. Circulation. 135:1788–1798. 2017.PubMed/NCBI View Article : Google Scholar

Pokushalov E, Romanov A, Katritsis DG, Artyomenko S, Bayramova S, Losik D, Baranova V, Karaskov A and Steinberg JS: Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: Early experience. Heart Rhythm. 11:1131–1138. 2014.PubMed/NCBI View Article : Google Scholar

Anselmino M, Matta M, D'Ascenzo F, Pappone C, Santinelli V, Bunch TJ, Neumann T, Schilling RJ, Hunter RJ, Noelker G, et al: Catheter ablation of atrial fibrillation in patients with diabetes mellitus: A systematic review and meta-analysis. Europace. 17:1518–1525. 2015.PubMed/NCBI View Article : Google Scholar

Gorenek B, Pelliccia A, Benjamin EJ, Boriani G, Crijns HJ, Fogel RI, Van Gelder IC, Halle M, Kudaiberdieva G, Lane DA, et al: European heart rhythm association (EHRA)/European association of cardiovascular prevention and rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the heart rhythm society (HRS) and Asia pacific heart rhythm society (APHRS). Europace. 19:190–225. 2017.PubMed/NCBI View Article : Google Scholar

Gu J, Liu X, Wang X, Shi H, Tan H, Zhou L, Gu J, Jiang W and Wang Y: Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus. Europace. 13:1256–1261. 2011.PubMed/NCBI View Article : Google Scholar

Fukamizu S, Sakurada H, Takano M, Hojo R, Nakai M, Yuba T, Komiyama K, Tatsumoto A, Maeno K, Mizusawa Y, et al: Effect of cigarette smoking on the risk of atrial fibrillation recurrence after pulmonary vein isolation. J Arrhythm. 26:21–29. 2010.

Lin KJ, Cho SI, Tiwari N, Bergman M, Kizer JR, Palma EC and Taub CC: Impact of metabolic syndrome on the risk of atrial fibrillation recurrence after catheter ablation: Systematic review and meta-analysis. J Interv Card Electrophysiol. 39:211–223. 2014.PubMed/NCBI View Article : Google Scholar

Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, Alasady M, Hanley L, Antic NA, McEvoy RD, et al: Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: The ARREST-AF cohort study. J Am Coll Cardiol. 64:2222–2231. 2014.PubMed/NCBI View Article : Google Scholar

Li L, Wang ZW, Li J, Ge X, Guo LZ, Wang Y, Guo WH, Jiang CX and Ma CS: Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: A meta-analysis of observational studies. Europace. 16:1309–1314. 2014.PubMed/NCBI View Article : Google Scholar

Matiello M, Nadal M, Tamborero D, Berruezo A, Montserrat J, Embid C, Rios J, Villacastín J, Brugada J and Mont L: Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace. 12:1084–1089. 2010.PubMed/NCBI View Article : Google Scholar

Naruse Y, Tada H, Satoh M, Yanagihara M, Tsuneoka H, Hirata Y, Ito Y, Kuroki K, Machino T, Yamasaki H, et al: Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: Clinical impact of continuous positive airway pressure therapy. Heart Rhythm. 10:331–337. 2013.PubMed/NCBI View Article : Google Scholar

Neilan TG, Farhad H, Dodson JA, Shah RV, Abbasi SA, Bakker JP, Michaud GF, van der Geest R, Blankstein R, Steigner M, et al: Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation. J Am Heart Assoc. 2(e000421)2013.PubMed/NCBI View Article : Google Scholar

Takigawa M, Takahashi A, Kuwahara T, Takahashi Y, Okubo K, Nakashima E, Watari Y, Nakajima J, Yamao K, Osaka Y, et al: Impact of alcohol consumption on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation. J Am Heart Assoc. 5(e004149)2016.PubMed/NCBI View Article : Google Scholar

Shah AN, Mittal S, Sichrovsky TC, Cotiga D, Arshad A, Maleki K, Pierce WJ and Steinberg JS: Long-term outcome following successful pulmonary vein isolation: Pattern and prediction of very late recurrence. J Cardiovasc Electrophysiol. 19:661–667. 2008.PubMed/NCBI View Article : Google Scholar

Suleiman M, Koestler C, Lerman A, Lopez-Jimenez F, Herges R, Hodge D, Bradley D, Cha YM, Brady PA, Munger TM, et al: Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: A double-blind, placebo-controlled, randomized trial. Heart Rhythm. 9:172–178. 2012.PubMed/NCBI View Article : Google Scholar

Macchia A, Grancelli H, Varini S, Nul D, Laffaye N, Mariani J, Ferrante D, Badra R, Figal J, Ramos S, et al: Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: Results of the FORWARD (randomized trial to assess efficacy of PUFA for the maintenance of sinus rhythm in persistent atrial fibrillation) trial. J Am Coll Cardiol. 61:463–468. 2013.PubMed/NCBI View Article : Google Scholar

Kowey PR, Reiffel JA, Ellenbogen KA, Naccarelli GV and Pratt CM: Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: A randomized controlled trial. JAMA. 304:2363–2372. 2010.PubMed/NCBI View Article : Google Scholar

Kumar S, Sutherland F, Morton JB, Lee G, Morgan J, Wong J, Eccleston DE, Voukelatos J, Garg ML and Sparks PB: Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion. Heart Rhythm. 9:483–491. 2012.PubMed/NCBI View Article : Google Scholar

Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM, Gheorghiade M and Dei Cas L: n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: A prospective, randomized study. Circulation. 124:1100–1106. 2011.PubMed/NCBI View Article : Google Scholar

Patel D, Shaheen M, Venkatraman P, Armaganijan L, Sanchez JE, Horton RP, Di Biase L, Mohanty P, Canby R, Bailey SM, et al: Omega-3 polyunsaturated fatty acid supplementation reduced atrial fibrillation recurrence after pulmonary vein antrum isolation. Indian Pacing Electrophysiol J. 9:292–298. 2009.PubMed/NCBI

Kolandaivelu A: Role of cardiac imaging (CT/MR) before and after RF catheter ablation in patients with atrial fibrillation. J Atr Fibrillation. 5(523)2012.PubMed/NCBI View Article : Google Scholar

Gimelli A, Ernst S and Liga R: Multi-modality imaging for the identification of arrhythmogenic substrates prior to electrophysiology studies. Front Cardiovasc Med. 8(640087)2021.PubMed/NCBI View Article : Google Scholar

Szili-Torok T, Kimman GJ, Scholten M, Thornton A, Ten Cate F, Roelandt J and Jordaens L: Ablation lesions in Koch's triangle assessed by three-dimensional myocardial contrast echocardiography. Cardiovasc Ultrasound. 2(27)2004.PubMed/NCBI View Article : Google Scholar

Schleberger R, Metzner A, Kuck KH, Andresen D, Willems S, Hoffmann E, Deneke T, Eckardt L, Brachmann J, Hochadel M, et al: Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation-Insights from the German ablation registry. Pharmacol Res Perspect. 9(e00880)2021.PubMed/NCBI View Article : Google Scholar

Duytschaever M, Demolder A, Phlips T, Sarkozy A, El Haddad M, Taghji P, Knecht S, Tavernier R, Vandekerckhove Y and De Potter T: PulmOnary vein isolation with vs without continued antiarrhythmic drug treatment in subjects with recurrent atrial fibrillation (POWDER AF): Results from a multicentre randomized trial. Eur Heart J. 39:1429–1437. 2018.PubMed/NCBI View Article : Google Scholar

Karasoy D, Gislason GH, Hansen J, Johannessen A, Køber L, Hvidtfeldt M, Özcan C, Torp-Pedersen C and Hansen ML: Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: Long-term follow-up in nationwide cohort of Denmark. Eur Heart J. 36:307–314a. 2015.PubMed/NCBI View Article : Google Scholar

Proietti R, AlTurki A, Di Biase L, China P, Forleo G, Corrado A, Marras E, Natale A and Themistoclakis S: Anticoagulation after catheter ablation of atrial fibrillation: An unnecessary evil? A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 30:468–478. 2019.PubMed/NCBI View Article : Google Scholar

Liu XH, Xu Q, Luo T, Zhang L and Liu HJ: Discontinuation of oral anticoagulation therapy after successful atrial fibrillation ablation: A systematic review and meta-analysis of prospective studies. PLoS One. 16(e0253709)2021.PubMed/NCBI View Article : Google Scholar

Chan P, Vijan S, Morady F and Oral H: Cost-effectiveness of left atrial catheter ablation, antiarrhythmic therapy, and rate control therapy for paroxysmal and chronic atrial fibrillation. Circulation. 111(e318)2005.

Eckard N, Davidson T, Walfridsson H and Levin LÅ: Cost-effectiveness of catheter ablation for patients with symptomatic atrial fibrillation. J Atr Fibrillation. 2(195)2009.PubMed/NCBI View Article : Google Scholar

Winkle RA, Mead RH, Engel G, Kong MH and Patrawala RA: Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes. J Interv Card Electrophysiol. 38:147–153. 2013.PubMed/NCBI View Article : Google Scholar

Winkle RA, Mead RH, Engel G, Kong MH and Patrawala RA: Physician-controlled costs: The choice of equipment used for atrial fibrillation ablation. J Interv Card Electrophysiol. 36:157–165. 2013.PubMed/NCBI View Article : Google Scholar

Weerasooriya R, Jaïs P, Scavée C, Macle L, Shah DC, Arentz T, Salerno JA, Raybaud F, Choi KJ, Hocini M, et al: Dissociated pulmonary vein arrhythmia: Incidence and characteristics. J Cardiovasc Electrophysiol. 14:1173–1179. 2003.PubMed/NCBI View Article : Google Scholar

Vijayaraman P, Dandamudi G, Naperkowski A, Oren J, Storm R and Ellenbogen KA: Assessment of exit block following pulmonary vein isolation: Far-field capture masquerading as entrance without exit block. Heart Rhythm. 9:1653–1659. 2012.PubMed/NCBI View Article : Google Scholar

Khaykin Y, Wang X, Natale A, Wazni OM, Skanes AC, Humphries KH, Kerr CR, Verma A and Morillo CA: Cost comparison of ablation versus antiarrhythmic drugs as first-line therapy for atrial fibrillation: An economic evaluation of the RAAFT pilot study. J Cardiovasc Electrophysiol. 20:7–12. 2009.PubMed/NCBI View Article : Google Scholar

Reynolds MR, Zimetbaum P, Josephson ME, Ellis E, Danilov T and Cohen DJ: Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol. 2:362–369. 2009.PubMed/NCBI View Article : Google Scholar

Assasi N, Blackhouse G, Xie F, Gaebel K, Robertson D, Hopkins R, Healey J, Roy D and Goeree R: Ablation procedures for rhythm control in patients with atrial fibrillation: Clinical and cost-effectiveness analyses. CADTH Technol Overv. 2(e2101)2012.PubMed/NCBI

Reynolds MR, Lamotte M, Todd D, Khaykin Y, Eggington S, Tsintzos S and Klein G: Cost-effectiveness of cryoballoon ablation for the management of paroxysmal atrial fibrillation. Europace. 16:652–659. 2014.PubMed/NCBI View Article : Google Scholar

McKenna C, Palmer S, Rodgers M, Chambers D, Hawkins N, Golder S, Van Hout S, Pepper C, Todd D and Woolacott N: Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom. Heart. 95:542–549. 2009.PubMed/NCBI View Article : Google Scholar

Aronsson M, Walfridsson H, Janzon M, Walfridsson U, Nielsen JC, Hansen PS, Johannessen A, Raatikainen P, Hindricks G, Kongstad O, et al: The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: Results from a MANTRA-PAF substudy. Europace. 17:48–55. 2015.PubMed/NCBI View Article : Google Scholar